Atlas Trials

Study Confirming A Human Challenge Model and Investigating The Safety Of VLA1701

Clinical trial NCT03576183 · COMPLETED

Trial details

NCT number
NCT03576183
Sponsor
Valneva Austria GmbH
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Enterotoxigenic Escherichia Coli InfectionDiarrhea
Start date
2018-06-04
Primary completion
2018-06-26
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.